Saturday 17 October 2026
Export STIM’s income statement to Excel — free account
Neuronetics, Inc.
STIM Healthcare Medical Devices
Neuronetics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $149.2 million, up 99.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.08%, EPS grew 66.7%, free cash flow grew 62.1% and total debt rose 10.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
1.89
0.06
−3.08%
Follow STIM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 3 | 4 | 3 |
+8 more TTM periods Free account |
| (114.52%) | (131.16%) | (134.39%) | (218.46%) | ||
| (22.87%) | (27.76%) | (27.61%) | (40.53%) | ||
ROIC |
(24.64%) | (31.09%) | (34.06%) | (37.93%) | |
Return on Tangible Assets |
(107.21%) | (163.03%) | (109.87%) | (108.85%) | |
Average Days of Receivables |
38.29 | 39.02 | 41.34 | 53.92 | |
Free Cash Flow per Share |
(0.15) | (0.19) | (0.32) | (0.45) | |
Free Cash Flow |
(11.22) | (13.56) | (21.17) | (30.55) | |
Capital Expenditures |
(0.92) | (0.75) | (0.80) | (0.67) | |
| Other line items | |||||
Cash ROIC |
(10.36%) | (13.89%) | (16.75%) | (23.20%) | |
Accounts Receivable Turnover |
7.23 | 7.04 | 7.24 | 6.75 | |
Accounts Payable Turnover |
7.13 | 7.92 | 7.05 | 8.66 | |
Inventory Turnover |
15.11 | 17.97 | 17.92 | 13.87 | |
Average Days of Payables |
57.45 | 52.88 | 51.01 | 65.62 | |
Days of Inventory on Hand |
25.45 | 21.81 | 20.55 | 24.50 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3.78% | 4.18% | 4.41% | 8.23% | |
Selling, General and Administrative Expense of Revenue |
60.08% | 63.18% | 65.14% | 71.35% | |
Share Based Compensation of Revenue |
3.84% | 4.67% | 4.59% | 4.58% | |
Interest Coverage |
(2.56) | (3.36) | (3.74) | (4.82) | |
Operating CF/Net income |
0.34 | 0.34 | 0.52 | 0.67 | |
Depreciation/Fixed assets |
0.90 | 0.85 | 0.78 | 0.64 | |
Capex/Depreciation |
(0.29) | (0.23) | (0.23) | (0.21) | |
Revenue per Share |
2.12 | 2.18 | 2.26 | 1.93 | |
Operating CF per Share |
(0.14) | (0.18) | (0.31) | (0.44) | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates